OPRM1 and Alzheimer disease: Indeed, our parallel comparison between DADLE and UFP-512 showed that the former did not induce the same neuroprotection as UFP-512, or even exacerbated the AD injury, which was very likely due to MOR activation, one of DADLE’s dual actions.